DHT Hair Loss: What Men Should Know

If you are noticing your hairline receding, crown thinning, or your hair looking less dense than it used to, you may have come across the term DHT hair loss.

DHT is closely linked to male pattern baldness, but having high DHT alone does not explain why some men develop hair loss while others do not. This article explains what DHT is, how it contributes to hair loss, who is more susceptible, how to recognize the pattern, and what treatment options can do about it.

What is DHT?

DHT stands for dihydrotestosterone, a hormone produced naturally from testosterone by an enzyme called 5-alpha-reductase.

In simple terms, your body produces testosterone, and 5-alpha-reductase converts approximately 10% of it each day into DHT. This conversion happens in tissues throughout the body, including the skin, liver, and prostate.

DHT is an androgen, which means it belongs to a group of hormones involved in the development of male sex characteristics. It is more potent androgen than testosterone, which is one reason it can have strong effects in certain tissues, including hair follicles.

But despite its link to hair loss, DHT is not a “bad” hormone. It has several normal functions in the body, including supporting male sexual development before birth and puberty-related changes such as voice deepening, genital maturation, facial and pubic hair growth, increased muscle mass, and skin oil production.

Is it possible for some men (and women) to have higher levels of DHT? Yes. DHT levels are influenced by several factors, including how much testosterone is available and how active 5-alpha-reductase is in different tissues. Higher enzyme activity can mean more testosterone gets converted into DHT.

However, it is a common misconception that hair loss is simply a side effect of having high DHT levels. The relationship between DHT and hair loss is more specific than that.

How Does DHT Cause Hair Loss?

DHT hair loss occurs when DHT binds to the androgen receptors in genetically sensitive hair follicles.

An androgen receptor is a part of the follicle that DHT can attach to. Think of it like a lock, with DHT acting like the key. Once DHT attaches to it, it can influence how that follicle behaves. In men with male pattern baldness, also known as androgenetic alopecia, this interaction can gradually trigger follicle miniaturization.

Follicle miniaturization means the follicle becomes smaller over repeated hair growth cycles. As this happens, the follicle starts producing hairs that are thinner, shorter, and less pigmented than before. The active growth phase, called the anagen phase, can also become shorter, so affected hairs do not grow as long or as thick before they shed.

This process does not cause hair to fall out all at once. Instead, it gradually changes the follicle’s output. Thick, pigmented terminal hairs may slowly become finer, vellus-like hairs that provide less scalp coverage. Over time, the follicle’s output becomes so fine that it is barely visible, and it may eventually stop producing visible hair altogether.

This gradual miniaturization is why male pattern baldness can progress for years before you start to notice a receding hairline, weaker hairs around your temples, thinning through your mid-scalp, or more visible scalp at your crown.

A 2021 animal study investigated how DHT affects hair growth. The researchers exposed mice commonly used in hair-growth research to DHT and observed changes resembling male pattern hair loss, including:

• Delayed regrowth
• A shorter growth phase of the hair cycle
• An earlier transition to the resting phase
• Reduced hair density
• Smaller follicles, and
• Thinner, shorter hairs

Because this was animal research, it does not prove the same process by itself in humans. However, it supports the clinical understanding that DHT can disrupt the normal hair growth cycle through androgen receptor activity, contributing to progressive follicle miniaturization.

Who Is More at Risk for DHT Hair Loss?

You are more at risk for DHT-related hair loss if male pattern baldness runs in your family, especially among close male relatives on either side of your family. The inherited risk is not usually about having unusually high DHT in your blood. It is more about how your hair follicles respond to DHT.

Research suggests that heredity accounts for about 80% of the predisposition to male pattern baldness. Genetics can influence androgen sensitivity, local 5-alpha-reductase activity, and which follicles are more likely to miniaturize over time.

A 1997 study on men and women with androgenetic alopecia compared follicles from their frontal scalp with follicles from the back of the scalp. Frontal follicles had higher levels of androgen receptors and 5-alpha-reductase, the enzyme that helps convert testosterone into DHT. Follicles from the back of the scalp had higher aromatase activity, which is associated with lower androgen sensitivity.

In simple terms, the areas most affected by pattern hair loss tend to have more of the machinery involved in DHT activity. They can convert testosterone into DHT more readily and may respond more strongly to it.

Blood DHT levels can be misleading on their own. A 2014 study found no significant difference in average blood DHT levels between people with androgenetic alopecia and people without hair loss. Higher blood DHT was not linked to more severe hair loss either.

So, DHT-related hair loss is not simply a sign of having “too much DHT.” It is usually the result of inherited follicle sensitivity and local androgen activity within susceptible follicles.

How to Know If DHT Is Causing Your Hair Loss

You cannot confirm DHT hair loss from one mirror check or photo. However, the pattern, location, and progression of the hair loss can give you useful clues.

DHT-related hair loss develops gradually and follows a recognizable pattern. You may notice recession at the temples, changes in the frontal hairline, thinning through the mid-scalp, or more visible scalp around the crown. The hairs in these areas may also become finer and shorter over time, while the back and sides of the scalp stay relatively dense. These changes can suggest androgenetic alopecia, especially if male pattern baldness runs in your family.

The Hamilton-Norwood scale can help you track your hair loss pattern more effectively. It is a standard staging system for male pattern baldness, used to group visible hair loss patterns from early hairline recession to advanced thinning across the top of the scalp. However, it does not measure DHT levels, follicle sensitivity, or follicle miniaturization directly.

If the pattern is unclear, a dermatologist can look beyond what you can see at home. They may ask about your family history, examine your scalp for signs of miniaturization, and check whether the thinning is concentrated in typical DHT-sensitive areas. They may also use dermoscopy or other methods for measuring hair density, especially when early changes are hard to judge with the naked eye alone.

Early DHT-related changes can be subtle. Lighting, hair length, styling, wet versus dry hair, camera angle, and distance can all produce significantly different impressions of the same scalp on the same day. If you are monitoring your hair loss at home, tracking the same scalp zones consistently over time gives you a reliable way to compare changes.

If your hair loss is sudden, patchy, affects the whole scalp evenly, or comes with scalp pain, itching, redness, or scaling, it may be caused by something other than DHT hair loss and should be checked by a dermatologist.

Can You Stop DHT Hair Loss?

DHT-related hair loss can often be slowed, stabilized, or partly improved, especially when it is treated early. However, treatment does not remove the underlying genetic susceptibility that makes certain follicles sensitive to DHT.

The most direct way to target DHT male pattern baldness is with DHT blockers, more accurately called 5-alpha-reductase inhibitors, such as finasteride and dutasteride. These medications reduce the conversion of testosterone into DHT. They can help slow miniaturization and preserve existing hair, but consistent use is usually needed to maintain results.

Other treatments may also be used to support hair growth. Minoxidil does not block DHT, but it can help stimulate follicle activity and extend the growth phase of the hair cycle. Some people also consider options such as platelet-rich plasma (PRP) therapy, low-level laser light therapy, microneedling, or hair transplantation, depending on the stage and pattern of hair loss.

The best treatment plan depends on how far the hair loss has progressed, how much miniaturization has occurred, your tolerance for medication, and your long-term goals.

FAQs

Does hair loss caused by DHT grow back?

DHT hair loss may partly improve if the follicles are still active and treatment starts early. Once follicles have miniaturized too far or stopped producing visible hair, full regrowth is less likely without hair transplantation.

What causes elevated DHT levels?

DHT levels can rise when your body has more testosterone available or when 5-alpha-reductase is more active. Genetics, age, anabolic steroid use and tissue-level enzyme activity can all influence how much DHT is produced.

How can I confirm if DHT is the cause of my hair loss?

You cannot confirm DHT hair loss from a mirror check or a blood DHT test alone. A dermatologist can assess your hair loss pattern, family history, scalp health, and signs of follicle miniaturization to determine whether androgenetic alopecia is likely.

Is blocking DHT harmful?

Blocking DHT can be safe and effective for many men when done with approved treatments such as finasteride or dutasteride, but side effects such as erectile dysfunction are possible. Speak with a clinician before starting treatment, especially if you have concerns about sexual, hormonal, or fertility-related side effects.

References

• Kinter, K. J., Amraei, R., & Anekar, A. A. (2023, July 30). Biochemistry, dihydrotestosterone. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK557634/
• Fu, D., Huang, J., Li, K., Chen, Y., He, Y., Sun, Y., Guo, Y., Du, L., Qu, Q., Miao, Y., & Hu, Z. (2021). Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia. Biomedicine & Pharmacotherapy, 137, 111247. https://doi.org/10.1016/j.biopha.2021.111247
• Asfour, L., Cranwell, W., & Sinclair, R. (2023, January 25). Male androgenetic alopecia. Endotext - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK278957/
• Sawaya, M. E., & Price, V. H. (1997). Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia. Journal of Investigative Dermatology, 109(3), 296–300. https://doi.org/10.1111/1523-1747.ep12335779
• Urysiak-Czubatka, I., Kmieć, M. L., & Broniarczyk-Dyła, G. (2014). Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia. Advances in Dermatology and Allergology, 4(4), 207–215. https://doi.org/10.5114/pdia.2014.40925